ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy

Eli Lilly and Company · 2004
ClinicalTrials.gov · Datasets · License: Public Domain · 2004
Open Source ↗
colorectal-neoplasms
colorectal neoplasms, metastases, neoplasm, egfr-undetectable, metastatic colorectal cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 811779
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.